Idamida®

Pomalidomide

Therapeutic action

Immunomodulatory agent.

Indications

  • Mantle cell lymphoma
  • Multiple myeloma
  • Myelodysplastic syndrome

Presentation

Hard capsules of 1 mg, 2 mg, 3 mg. and 4 mg.